Indo Us Bio-Tech Limited (BOM:541304)
85.04
-1.02 (-1.19%)
At close: Aug 21, 2026
Indo Us Bio-Tech Revenue
Indo Us Bio-Tech had revenue of 329.87M INR in the quarter ending June 30, 2026, with 7.21% growth. This brings the company's revenue in the last twelve months to 1.13B, up 2.52% year-over-year. In the fiscal year ending March 31, 2026, Indo Us Bio-Tech had annual revenue of 1.10B with 6.36% growth.
Revenue (ttm)
1.13B
Revenue Growth
+2.52%
P/S Ratio
1.51
Revenue / Employee
n/a
Employees
883
Market Cap
1.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.10B | 66.01M | 6.36% |
| Mar 31, 2025 | 1.04B | 310.02M | 42.56% |
| Mar 31, 2024 | 728.36M | 110.92M | 17.96% |
| Mar 31, 2023 | 617.45M | 116.86M | 23.34% |
| Mar 31, 2022 | 500.59M | 99.48M | 24.80% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JK Agri Genetics | 1.50B |
| Mangalam Seeds | 1.25B |
| Tierra Agrotech | 1.12B |
| Sheel Biotech | 1.10B |
| Saptarishi Agro Industries | 937.03M |
| Stanbik Agro | 858.95M |
| Nagarjuna Agri-Tech | 832.38M |
| Unisem Agritech | 810.34M |
Indo Us Bio-Tech News
- 2 years ago - Indo US Bio-Tech share price surges 3% after signing MoU for Pratap Hybrid Maize -6 - Business Upturn